Page last updated: 2024-08-05 11:09:33
extended flavonoid
Any flavonoid with one or more rings fused on to the phenyl substituted benzopyran framework.
ChEBI ID: 71037
Members (8)
Member | Definition | Role |
---|---|---|
5-methoxy-8,8-dimethyl-2-phenyl-4H,8H-pyrano[2,3-h]chromen-4-one | 5-methoxy-8,8-dimethyl-2-phenyl-4H,8H-pyrano[2,3-h]chromen-4-one | |
alpha-naphthoflavone | An extended flavonoid resulting from the formal fusion of a benzene ring with the h side of flavone. A synthetic compound, it is an inhibitor of aromatase (EC 1.14.14.14). | alpha-naphthoflavone |
beta-naphthoflavone | An extended flavonoid resulting from the formal fusion of a benzene ring with the f side of flavone. | beta-naphthoflavone |
Cudraflavone A | Cudraflavone A | |
cycloheterophyllin | Cycloheterophyllin | |
karanjin | Karanjin | |
morusin | An extended flavonoid that is flavone substituted by hydroxy groups at positions 5, 2' and 4', a prenyl group at position 3 and a 2,2-dimethyl pyran group across positions 7 and 8. | morusin |
muromonab-cd3 | An extended flavonoid that consists of a pyranochromane skeleton that is 2H,6H-pyrano[3,2-g]chromen-6-one substituted by geminal methyl groups at position 2, a 2,4-dihydroxyphenyl group at position 8, a hydroxy group at position 5 and a prenyl group at position 7. Isolated from Morus alba and Morus species it exhibits anti-inflammatory activity. | cudraflavone B |
Research
Studies (1,846)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 493 (26.71) | 18.7374 |
1990's | 522 (28.28) | 18.2507 |
2000's | 420 (22.75) | 29.6817 |
2010's | 320 (17.33) | 24.3611 |
2020's | 91 (4.93) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 2 (0.10%) | 5.53% |
Reviews | 26 (1.27%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 1 (0.05%) | 0.25% |
Other | 2,023 (98.59%) | 84.16% |